Together with our network of international partners, we consider it essential to fully investigate cannabis-based medicine in order to understand their mode of action. Based on this research, we are constantly improving our product-portfolio and developing new preparations made from the cannabis plant. We have the ambition to provide patients, with the best possible cannabinoid-treatment and provide physicians and pharmacists with education about the cannabis-plant.
Our International Network of R&D partners
Connect 4
Connect 4 is founding partner of CanPharma and is extending our expertise, when it comes to questions regarding market access for pharmaceuticals and medical devices. Among others Connect 4 has years of experiences in the fields of regulatory affairs, market intelligence, market entry and market penetration. Together with the Connect 4 team, we are expanding the variety of products on the market with new, great cannabis-based pharmaceuticals.
Do you have any questions?
MEMBER OF
